In Case You Missed It: Three Things We Learned From the Evaluate Vantage 2023 Preview Webinar
Missed out latest webinar? Fear not, here are three things we learned from the 2023 Preview discussion. And the webinar is available on demand now. It is now officially too late to say “Happy new year” to people you’ve not seen since December, but it’s not quite too late to be looking ahead to what […]
More in Hope than Expectation: Biopharma in 2023
Few people are expecting biopharma to stage a spectacular comeback in 2023 but what can we reasonably hope for – and when? I joined the world of biopharma in 2022 and it seems I didn’t pick a vintage year. M&A activity was weak, share prices plummeted and IPOs were all but non-existent. However, I have […]
Machine Learning and Intelligent Forecasting: Beyond the Black Box
The black box. That mysterious widget in which myriad magic tricks reside. For some it is a magical force that delivers exactly what you need, even if you don’t entirely understand how. For others, it is at best untrustworthy and at worst, dangerous. And any solution that offers machine learning, artificial intelligence or predictive analytics […]
What to expect from JP Morgan 2023
The real start to the biopharma year, the JP Morgan Healthcare Conference, is nearly upon us. As the holidays fade into memory – along with a pretty rough 2022 – what will this bellwether of the industry bring? I caught up with one of Evaluate’s VP consultants, Vinay Bhaskar, who’ll be in San Francisco as […]
Meet the Evaluate Team: Ulyssa MacMillan
Evaluate is awash with team members who ensure our products are best in class, while also being splendid people to have around. In our latest edition of the Meet the Team series, we meet Ulyssa MacMillan, VP Product: Platform. With over eight years at Evaluate under her belt, there’s lots to cover, not least her […]
What is Intelligent Forecasting?
Intelligent forecasting is a hugely powerful tool for the life sciences industry…but what exactly IS it? These days we are not short on buzzwords around artificial intelligence. While experts can wax lyrical about the differences between AI, machine learning, and natural language processing, mere mortals are often left scratching their heads. For many people, it’s […]
Meet the Evaluate Team: Andreas Hadjivasiliou
Behind Evaluate’s data and insights about the biopharma space, there are people who work to make sure that our clients have the data and insight they need to make the right decisions for their business. In the latest of our Meet the Team blog series, we speak to Andreas Hadjivasiliou, Managing Analyst, Data Operations about […]
Evaluating the London Marathon
Running a marathon is never easy, but the right motivation (and peanut butter) certainly help. The last time I ran the London Marathon, it was grim. It was 2018 and a cold snap in March meant I was training in snow and when the event came around in April, it was the hottest on […]
Meet the Evaluate Team: Christina Kay
Behind Evaluate’s data and insights about the biopharma space, there are people who work to make sure that our clients have everything they need to make their lives a little easier (at work, at least). In the latest of our Meet the Team blog series, we speak to Christina Kay, VP, Global Customer Success about […]
Medtech in 2028: Suffering or Celebrating a COVID Hangover?
We’ve extended our forecasts out to 2028 and in our latest report, we take a look at what’s in store for the medtech market in the next few years. It seems obvious to say that Covid had a massive impact on the medtech industry but being obvious doesn’t stop the statement being true. Several […]
